Friday Nov 22
Cutting Heart Risk From Obesity: Treat The Symptoms Or The Cause?
A huge new study out today in The Lancet shows that reducing three key factors linked to obesity - high blood pressure, blood sugar, and cholesterol - could cut heart disease in obese people by half.
Analysis Of Intercept Pharmaceutical And OCA's Future Potential
Introduction Intercept Pharmaceuticals is developing a first-in-class drug, obeticholic acid that modulates bile production to reduce liver stress.
Medical Device/Diagnostic Ind.
2013 Medtech M&A Review: 3 Aesthetic-Focused Transactions
Cynosure Inc., a leader in laser and light-based treatment for both minimally invasive and noninvasive aesthetic procedures, acquired competitor Palomar Medical Technologies for approximately $287 million .
BofA Merrill Lynch Fund Manager Survey Finds Confidence in Global...
With political paralysis in Washington overcome, a net 67 percent of respondents now expect the world's economy to strengthen over the next 12 months - up a notable 13 percentage points from October.